Quantitative shape analysis of chemoresistant colon cancer cells: Correlation between morphotype and phenotype

Experimental Cell Research

Volumn 318, Issue 7, 2012, Pages 835-846

  Pasqualato, A ^a   Palombo, A ^b   Cucina, A ^b   Mariggio M A ^a   Galli, L ^c   Passaro, D ^c   Dinicola, S ^b   Proietti, S ^b   D'Anselmi, F ^b   Coluccia, P ^b   Bizzarri, M ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Advanced Computer Systems SpA   (Italy)

Author keywords

5 fluorouracil; Cell morphology; Cell shape analysis; Chemoresistance; Colon cancer cells; Normalized bending energy

Indexed keywords

FLUOROURACIL;

ALGORITHM; APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL DENSITY; CELL MEMBRANE; CELL POPULATION; CELL PROLIFERATION; CELL SHAPE; CELL STRUCTURE; CHEMOSENSITIVITY; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 84858276789     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.01.022     Document Type: Article

References (53)

1. Watson P.A. Function follows form: generation of intracellular signals by cell deformation. FASEB J. 1991, 5:2013-2019.
2. Chen C.S., Mrksich M., Huang S., Withesides G.M., Ingber D.E. Geometric control of cell life and death. Science 1997, 276:1425-1428.
3. Nelson C.M., Khauv D., Bissell M.J., Radisky D.C. Change in cell shape is required for matrix metalloproteinase-induced epithelial-mesenchymal transition of mammary epithelial cells. J. Cell. Biochem. 2008, 105:25-33.
4. Bannikov G.A., Guelstein V.I., Montesano R., Tint I.S., Tomatis L., Troyanovsky S.M., Vasiliev J.M. Cell shape and organization of cytoskeleton and surface fibronectin in non-tumorigenic and tumorigenic rat liver cultures. J. Cell Sci. 1982, 54:47-67.
5. Losa G.A., Nonnenmacher T.F., Weibel E.R. Fractals in biology and medicine 2002, Vol. III. Birkhäuser Editor, Basel, Switzerland.
6. D'Anselmi F., Valerio M., Cucina A., Galli L., Proietti S., Dinicola S., Pasqualato A., Manetti C., Ricci G., Giuliani A., Bizzarri M. Metabolism and cell shape in cancer: a fractal analysis. Int. J. Biochem. Cell Biol. 2011, 43:1052-1058.
7. Gazdar A.F., Carney D.N., Nau M.N., Minna J.D. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological and growth properties. Cancer Res. 1985, 45:2924-2930.
8. Heckman C.A., Jamasbi R.J. Describing shape dynamics in transformed cells through latent factors. Exp. Cell Res. 1999, 246:69-82.
9. Krasowska M., Grzywna Z.J., Mycielska M.E., Djamgoz M.B. Patterning of endocytotic vesicles and its control by voltagegated Na+ channel activity in rat prostate cancer cells: fractal analyses. Eur. Biophys. J. 2004, 33:535-542.
10. Uppal S.O., Li Y., Wendt E., Cayer M.L., Barnes J., Conway D., Boudreau N., Heckman C.A. Pattern analysis of microtubule-polymerizing and depolymerising agent combinations as cancer chemotherapies. Int. J. Oncol. 2007, 31:1281-1291.
11. Cristini V., Frieboes H.B., Gatenby R., Caserta S., Ferrari M., Sinek J. Morphologic instability and cancer invasion. Clin. Cancer Res. 2005, 11:6772-6779.
12. Ferreira S.C., Martins M.L., Villa M.J. Morphology transitions induced by chemotherapy in carcinomas in situ. Phys. Rev. E 2003, 67:1-9.
13. Heckman C.A., Campbell A.E., Wetzel B. Characteristic shape and surface changes in epithelial transformation. Exp. Cell Res. 1987, 169:127-148.
14. Olson A.C., Larson N.M., Heckman C.A. Classification of cultured mammalian cells by shape analysis and pattern recognition. Proc. Natl. Acad. Sci. 1980, 77:1516-1520.
15. Heckman C.A. Geometrical constraints on the shape of cultured cells. Cytometry 1990, 11:771-783.
16. Dokukin M.E., Guz N.V., Gaikwad R.M., Woodworth C.D., Sokolov I. Cell surface as a fractal: normal and cancerous cervical cells demonstrate different fractal behavior of surface adhesion maps at the nanoscale. Phys. Rev. Lett. 2011, 107:028101.
17. Sedivy R., Windischberger C., Svozil K., Moser E., Breitenecker G. Fractal analysis: an objective method for identifying atypical nuclei in dysplastic lesions of the cervix uteri. Gynecol. Oncol. 1999, 75:78-83.
18. Anderson A.R., Quaranta V. Integrative mathematical oncology. Nat. Rev. Cancer 2008, 8:227-234.
19. Timbo C., da Rosa L.A.R., Gonçalves M., Duarte S.B. Computational cancer cells identification by fractal dimension analysis. Comput. Phys. Commun. 2009, 180:850-853.
20. Marshall W.F. Origins of cellular geometry. BMC Biol. 2011, 9:57-71.
21. Du Q., Liu C., Wang X. A phase field approach in the numerical study of the elastic bending energy for vesicle membranes. J. Comput. Phys. 2004, 198:450-468.
22. Bowie J.E., Young I.T. An analysis technique for biological shape-II. Acta Cytol. 1977, 21:455-464.
23. Cesar R.M., da F.Costa L. Application and assessment of multiscale bending energy for morphometric characterization of neural cells. Rev. Sci. Instrum. 1997, 68:2177-2186.
24. Young I.T., Walker J.E., Bowie J.E. An analysis technique for biological shape. I. Inf. Control. 1974, 25:357-370.
25. Worring M., Smeulders A.W.M. Digital Curvature Estimation. Image Understanding 1993, 58:366-382.
26. Rosin P.L. Multiscale representation and matching of curves using codons. Graph. Models Image Process. 1993, 55:286-310.
27. Bohr T., Tél T. The thermodynamics of fractals. Directions in Chaos 1988, Vol. 2. World Scientific, Singapore. H. Bai-Lin (Ed.).
28. Dinicola S., D'Anselmi F., Pasqualato A., Proietti S., Lisi E., Cucina A., Bizzarri M. A systems biology approach to cancer: fractals, attractors, and nonlinear dynamics. OMICS 2011, 15:93-104.
29. Yang A.D., Fan F., Camp E.R., van Buren G., Liu W., Somcio R., Gray M.J., Cheng H., Hoff P.M., Ellis L.M. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin. Cancer Res. 2006, 12:4147-4153.
30. Dallas N.A., Xia L., Fan F., Gray M.J., Gaur P., van Buren G., Samuel S., Kim M.P., Lim S.J., Ellis L.M. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res. 2009, 69:1951-1957.
31. Gebäck T., Schulz M.M.P., Koumoutsakos P., Detmar M. A novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 2008, 46:265-274.
32. Sebri A., Malek J., Tourki R. Automated breast cancer diagnosis based on GVF-snake segmentation, wavelet features extraction and neural network classification. J. Comput. Sci. 2007, 3:600-607.
33. Xu C., Prince J.L. Generalized gradient vector flow external forces for active contours. Signal Process. 1998, 71:131-139.
34. Cesar R.M., da F.Costa L. 13th Int. Conf. Pattern Recognition, Vienna, Austria 1996.
35. Momand J., Wu H.H., Dasgupta G. MDM2-master regulator of the p53 tumor suppressor protein. Gene 2000, 242:15-29.
36. Yamane N., Makino M., Kaibara N. S-phase accumulation precedes apoptosis induced by preoperative treatment with 5-fluorouracil in human colorectal carcinoma cells. Cancer 1999, 85:309-317.
37. Yoshikawa R., Kusunoki M., Yanagi H., Noda M., Furuyama J.I., Yamamura T., Hashimoto-Tamaoki T. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res. 2001, 61:1029-1037.
38. Longley D.B., Harkin D.P., Johnston P.G. 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 2003, 3:330-338.
39. De Rozieres S., Maya R., Oren M., Lozano G. The loss of MDM2 induces p53-mediated apoptosis. Oncogene 2000, 19:1691-1697.
40. Inoue T., Geyer R.K., Yu Z.K., Maki C.G. Downregulation of MDM2 stabilizes p53 by inhibiting p53 ubiquitination in response to specific alkylating agents. FEBS Lett. 2001, 490:196-201.
41. Proietti S., Cucina A., D'Anselmi F., Dinicola S., Pasqualato A., Lisi E., Bizzarri M. Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells. J. Pineal Res. 2011, 50:150-158.
42. Altieri D.C. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr. Opin. Cell Biol. 2006, 18:609-615.
43. Zhang T., Otevrel T., Gao Z., Gao Z., Ehrlich S.M., Fields J.Z., Boman B.M. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res. 2001, 61:8664-8667.
44. Whitfield J.F. Calcium, calcium-sensing receptor and colon cancer. Cancer Lett. 2009, 275:9-16.
45. Fang Y.J., Lu Z.H., Wang G.Q., Pan Z.Z., Zhou Z.W., Yun J.P., Zhang M.F., Wan D.S. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Int. J. Colorectal Dis. 2009, 24:875-884.
46. Kim K., Chie E.K., Wu H.G., Kim S.G., Lee S.H., Kang G.H., Hyun C.L., Ha S.W. High survivin expression as a predictor of poor response to preoperative chemoradiotherapy in locally advanced rectal cancer. Int. J. Colorectal Dis. 2011, 26:1019-1023.
47. Palmer T.D., Ashby W.J., Lewis J.D., Zijlstra A. Targeting tumor cell motility to prevent metastasis. Adv. Drug Deliv. Rev. 2011, 63:568-581.
48. Du Q., Liu C., Wang X. Simulating the deformation of vesicle membranes under elastic bending energy in three dimensions. J. Comput. Phys. 2006, 212:757-777.
49. Foty R., Pfleger C., Forcas G., Steimberg M. Surface tensions of embryonic tissues predict their mutual envelopment behaviour. Development 1996, 122:1611-1620.
50. Smith T.G., Lange G.D., Marks W.B. Fractal methods and results in cellular morphology, dimensions, lacunarity and multifractals. J. Neurosci. Methods 1996, 69:123-136.
51. Foty R., Forgacs G., Pfleger C., Steimberg M. Liquid properties of embryonic tissues: measurement of interfacial tensions. Phys. Rev. Lett. 1994, 72:2298-2301.
52. Tsuruo T., Yamori T., Naganuma K., Tsukagoshi S., Sakurai Y. Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 261. Cancer Res. 1983, 43:5437-5442.
53. Rohrschneider M., Scheuermann G., Hoehme S., Drasdo D. Shape characterization of extracted and simulated tumor samples using topological and geometric measures. Engineering in Medicine and Biology Society, Proceedings of the 29th Annual International Conference of the IEEE EMBS, Lyon, France 2007, 6271-6277.